PDFファイル - 医薬品医療機器総合機構
Contents
1. CIN2 PPV Posiive Predictive Value NPV Negative Predictive Value 72 196 49 92 696 63 19 16 84 29 HPV NPV 95 89 98 89 CIN2 1 29 5 424 4 2 19 454 17 3 HPV CIN22. CIN2 PPV NPV 72 1 62 3 15 7 95 8 42 68 435 698 49 312 435 454 92 6 eo 0 18 4 98 8 63 68 419 698 63 342 419 424 1 HBV HIV HCV 1 2 3 4 1 59 6 2
3. 1 1 3 250 RLU 3 RLU CV 259 CV 259 2 CV 259 6 HPV 3 RLU CV 20 CV 209 2 CV 209 HPV 2 0 2 HPV 3
4. 1 0 mL 0 2 mL 0 8 mL SurePah 2 0 mL 2 8 mL 15 mL 800 x g 10 Specimen Trqnspor Aedium STM 200L 15 5 30 100L 5
5. 60 4 100L 8 20 25 C 1 100 rpm 60 2 3 5 1 75L 20 25 C 30 6 2 75L 20 25 C 15 2 15
6. 5 PC 7 PC 8 1 9 HPV 2 10 96 3 50 mL 140 0L 48 1 75 mL 70 0L 2 RT 20 HPV 16 9990 990 500L 1 000L 8 OI 80 2 3 1 4 2 ie TRI 5 5 WE A 2
7. 1 DNA RNA 2 Disodium 2 chloro 5 4 methoxyspiro 1 2 dioxethane 3 2 5 chloro ricyclo 3 3 1 1 decan1 4 y 1 phenyl phosphole 79 6 HPV HPV DNA ASC US ASC US LSIL HPV HPV DNA HCI HPV DNA DNA HPV HPV DNA
8. 5 HPV 3 1 60 NC HPV PC 1 1 2 3 1 HPV A NC 3 11 HPV B NC 4 12 HPV C NC 5 13 25 1 D PC 6 14 E F G H 4
9. 0 pg mL 4 5 5 5 pg mL 3 HPV DNA HPV16 DNA 1 0 pg mL HPV pg mD 16 0 94 1 29 18 0 88 1 29 31 0 91 1 15 33 1 26 1 45 35 0 95 1 31 39 1 16 1 71 45 0 99 1 35 51 0 70 0 88 52 1 21 1 58 56 0 58 0 67 58 0 73 0 94 59 1 00 1 21 68 1 03 1 39 4 18 46 000 ASC US 785 HPV 1 ASC US ASC US 785 354 45 1 HPV
10. 69 8 8 CIN2 92 8 64 69 NPV Negative Predictive Volue 98 89 426 431 431 5 1 29 ASC US CIN2 ASC US CIN2 TOTAL HPV DNA 64 290 354 HCI 5 426 431 HPV TOTAL 69 716 785 2 ASC US ASC US 766
11. 3 CV 20 2 3 lt 1 0 1 0 2 1 HPV HPV DNA 2 HPV 3 4 0 pg mL 4 5 5 5 pg mL
12. 2010 11 1 21400AMY00019000 Cat No 618915 HPV DNA HCI ASC US HPV 1 HPV HPV RNA DNA RNA
13. 65 90 2 3 2 107 mnL DNA RNA DML2000 4 0 ng mL Acinetobacter anitratus Acinetobacter lwoffi Bacteroides fragilis Bacteroides melaninogenicus Candida albicans Chlamydia trachomatis Enterobacter cloacae Escherichia coli HB101 b Escherichia coli Fusobacterium nucleatum Gardnerella vaginalis 65 Haemophilus ducreyi Klebsiella pneumoniae Lactobacillus acidophilus Mobiluncus curtisii Mobiluncus mulieris 20 lt 200L
14. 6 a 7 8 et 3 1 1 000 ppm 1 2 1 121 C 20 2 1 59 6 3 1 2C8C 2 1 HPV 0 2 mLx1 96 x1 1 12 mLx1 2 12 mLx1 5 0 mLx 1 HCI _ 96 50 mLx 1
15. 100 mLx 1 0 35 mLx 1 2 0 mLx 1 HPV 1 0 mLx1 1 IARC WHO IARC Handbooks of Cancer Prevention Vol 10 IARC Press 2005 2 93 9 1575 1582 2005 3 39 4 849 853 1998 4 73 3 233 238 1999 5 Clavel C Masure M Bory JP et ql Briish J Cancer 80 9 1306 1311 1999 6 Nobbenhuis MAE Walboomers JAM Helmerhorst TJM et al Lancet 354 20 25 1999 104 0054 3 13 1 Forefront Tower ll Tel 03 6890 7300 E mail lechservice jp qiagen com 3 13 1 Forefront Tower ll QKK PI618915 02
16. DNA RNA DNA RNA DNA RNA HPV DNA 1 16 18 31 33 35 39 45 51 52 56 58 59 68 13 HPV 2 RNA DNA RNA 96 3 1 1 2 3 2 1 2 8C 20 C
17. 200 1 000 gL Mycoplasma hyorhinis Mycoplasma hominis Neisseria gonorrhoeae Neisseria lactamica Neisseria meningitidis 8 Nejsserig sicca Peptostreptococcus anaerobius Proteus vulgaris 8 Serratia morcescens Sfopnyjococcus epidermidis Staphylococcus faecalis Staphylococcus pyogenes Treponemo pallidum Trichomonas vaginalis Ureaplasma urealyticum Staphylococcus aureus Cowen srain Adenovirus 2 Cytomegalovirus Epstein Bqrr Virus Herpes Simplex virus I Herpes Simplex virus II Human Immunodeficiency Virus HIV 2 A 5 HPV B 13 HPV 16 18 31 33 35 39 45 51 52 56 58 59 68 HPV DNA 10 0 pg mL 13 HPV
18. 3 DNA 4 4C 20 3 3 3 3 5 6 7 LBC ThinPrep SurePath 3 3 ThinPrep PreservCyt hc2 Sample Conversion Kit 5127 1220 SurePath
19. 1 2 3 4 5 2 1 2
20. 8 C 3 65C 45 5 3 6 0 eS 25L o 100 mL 2 900 mL 30 7 75uL 8 HPV 1 100 rpm 3 25uL 65C
Download Pdf Manuals
Related Search